Skip to content

Clinical trials

Phase 2/3 Atherosclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 2/3 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20042
20052
20061
20071
20084
20092
20101
20111
20131
20181
20192
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status7
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Aging (NIA)3
UMC Utrecht2
University Hospital Tuebingen2
University of Sao Paulo General Hospital2
Anesiva, Inc.1
Brigham and Women's Hospital1
CSL Behring1
Chugai Pharma USA1
Daiichi Sankyo1
Dr. Grant Pierce1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis28
Coronary Artery Disease7
Cardiovascular Diseases5
Diabetes Mellitus4
Inflammation4
Peripheral Arterial Disease3
Peripheral Vascular Diseases3
Diabetes Mellitus, Type 22
Graft Occlusion, Vascular2
Insulin Resistance2

Trials

Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.